Exact Mass: 456.3253
Exact Mass Matches: 456.3253
Found 248 metabolites which its exact mass value is equals to given mass value 456.3253
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Docosahexaenoyl Lysine
N-docosahexaenoyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Lysine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
12alpha-acetoxy-20,24beta-dimethylscalar-17-en-25,24-lactone|12alpha-acetoxy-20,24beta-dimethylscalar-17-eno-25,24-lactone
20alpha-dimethylamino-16beta-hydroxy-3-senecioylamino-5alpha-pregn-2-en-4-one|pachysamine N
3-Ketone-(3alpha,11alph)-3,11-Dihydroxy-24-nor-20(29)-lupen-28-oic acid
24xi-hydroperoxy-24-ethylcholesta-4,28(29)-dien-3,6-dione
3-oxo-1beta-hydroxy-2-nor-1,3-cyclotirucalla-7,24-dien-21-oic acid|dysoxyhainic acid A
(2beta,3beta)-2,3,23-Trihydroxy-28-nor-5,12-oleanadien-16-one|mimusopgenone
30-norhederagenin|3beta,23-dihydroxy-30-norolean-12,20(29)-dien-28-oic acid
3beta,6beta-dihydroxy-24-noroleana-12,4(23)-dien-27-oic acid
2alpha,3alpha-dihydroxy-24-nor-4(23)-oleandien-28-oic acid|2alpha,3alpha-dihydroxy-24-nor-olean-4(23),12-dien-28-oic acid
2alpha,3beta-dihydroxy-30-noroleana-12,20(29)-dien-28-oic acid|2??,3??-Dihydroxy-30-noroleana-12,20(29)-dien-28-oic acid
3beta,16beta-dihydroxy-30-norolean-12,20(29)-dien-28-oic acid|pfaffianol A|pfaffine A
3,20-dioxo-29-norlupan-28-oic acid|3,20-dioxo-30-norlupan-28-oic acid
(12beta,22R)-12-acetoxy-22-hydroxy-cholesta-1,4-dien-3-one
2alpha,3beta-dihydroxy-24-nor-urs-4(23),12-dien-28-oic acid|ilekudinol B
(12beta,22R)-12-hydroxy-22-acetoxy-cholesta-1,4-dien-3-one
(20R,22R)-20-hydroxy-22-acetoxy-cholesta-1,4-dien-3-one
3beta,21alpha-dihydroxy-27-oxo-30-nor-(D:A)-friedo-olean-20(29)-en-27,22alpha-lactone|glaucalactone
(+)-(3S,7S,8S,13R,14S,17R,18R,21S)-25-norfern-5(10),9(11)-diene-19-oxo-3,7,28-triol
28-Noroleana-16,21-diene-3alpha,19alpha,29-triol-23-al
(19alpha)-19-hydroxy-3-oxo-24-norolean-12-en-28-oic acid
(22E)-2-ethoxycarbonyl-2-beta-hydroxy-A-nor-cholest-5,22-diene-4-one|2-ethoxycarbonyl-2beta-hydroxy-A-nor-cholesta-5,22-dien-4-one
(20S,22R)-5alpha-spirost-25(27)-en-3beta-ol monoacetate
aglaiabbreviatin B
A tetracyclic triterpenoid isolated from the stems of Aglaia abbreviata.
12alpha-acetoxy-13beta,18beta-cyclobutane-20,24-dimethyl-24-oxoscalar-16-en-25alpha-ol|12alpha-acetoxy-13beta,18beta-cyclobutane-20,24-dimethyl-24-oxoscalar-16-en-25beta-ol
3-oxo-1alpha-hydroxy-2-nor-1,3-cycloolean-12-en-30-oic acid|dysoxyhainic acid B
Ile Ile Ile Val
Ile Ile Leu Val
Ile Ile Val Ile
Ile Ile Val Leu
Ile Leu Ile Val
Ile Leu Leu Val
Ile Leu Val Ile
Ile Leu Val Leu
Ile Val Ile Ile
Ile Val Ile Leu
Ile Val Leu Ile
Ile Val Leu Leu
Leu Ile Ile Val
Leu Ile Leu Val
Leu Ile Val Ile
Leu Ile Val Leu
Leu Leu Ile Val
Leu Leu Leu Val
Leu Leu Val Ile
Leu Leu Val Leu
Leu Val Ile Ile
Leu Val Ile Leu
Leu Val Leu Ile
Leu Val Leu Leu
Val Ile Ile Ile
Val Ile Ile Leu
Val Ile Leu Ile
Val Ile Leu Leu
Val Leu Ile Ile
Val Leu Ile Leu
Val Leu Leu Ile
Val Leu Leu Leu
(5Z,7E)-(1S,3R,22S)-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20R,22R)-24a,24b-dihomo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20R,22S)-24a,24b-dihomo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20R,22R)-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R)-18-(5-hydroxy-5-methyl-2-hexynyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
(5Z,7E)-(1S,3R)-18-(5-hydroxy-5-methyl-3-hexynyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
(22R)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a,24b-dihomo-20-epivitamin D3
(22S)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a,24b-dihomo-20-epivitamin D3
(22R)-1alpha,22,25-trihydroxy-26,27-dimethyl-23,24-tetradehydro-20-epivitamin D3
Dequalinium
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AC - Quinoline derivatives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AH - Quinoline derivatives R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AA - Antiseptics C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents
[3-carboxy-2-[(Z)-17-carboxyheptadec-9-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-17-carboxyheptadec-9-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-17-carboxyheptadec-11-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(10E,12E)-9-hydroperoxyoctadeca-10,12-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(9E,11E)-13-hydroperoxyoctadeca-9,11-dienoyl]oxypropyl]-trimethylazanium
(1R,9R,10S,12R,13S,14R,15R,16S,17S,18R)-15-[3-(diethylamino)-2-hydroxypropyl]-13-ethyl-8-methyl-8-aza-15-azoniahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol
D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
3beta,23-Dihydroxy-30-nor-olean-12,20-dien-28-oic acid
A natural product found in Paeonia rockii subspeciesrockii.
[1-carboxy-3-[2-hydroxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium
(25R)-12alpha-hydroxy-24R,26R-dimethyl-26,27-cyclo-cholest-4-en-3,6-dione
(1r,5s,6s,9r,10r,13s,14r,16r)-13-[(2r)-2-hydroxy-6-methyl-4-oxohept-5-en-2-yl]-5,9,10-trimethyl-6-(prop-1-en-2-yl)-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-3-one
(1r,3as,3br,9ar,9bs,11as)-1-[(2r,5r)-5-ethyl-5-hydroxy-6-methylhept-6-en-2-yl]-9a-methyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid
(1r,3s,3ar,5ar,5br,7ar,9r,11br,13ar,13br)-3,9-dihydroxy-3a-(hydroxymethyl)-5a,5b,8,8-tetramethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,11bh,12h,13h,13ah,13bh-cyclopenta[a]chrysen-10-one
methyl (1s,2r,4s,9s,10s,13r,14r)-13-[(2r,3e)-5,6-dimethylhept-3-en-2-yl]-4-hydroxy-2,14-dimethyl-5-oxotetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-6-ene-4-carboxylate
(9ar,11ar)-1-[(2r)-5-hydroperoxy-5-isopropylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione
(4as,6as,6br,9r,10r,11s,12ar,12bs,14br)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,4a,6,7,10,11,12,12b,13,14b-dodecahydropicen-5-one
(4ar,5r,6as,6br,8as,9r,12as,14bs)-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-10-oxo-1,3,4,5,6,7,8,8a,9,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
10,11-dihydroxy-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(4as,6as,6br,8ar,9s,10r,12ar,12br,14bs)-10-hydroxy-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
2,3-dimethoxy-5-methyl-6-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]benzene-1,4-diol
(2r,2ar,5as,5br,7as,8s,11as,11br,13s,13as)-3-acetyl-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-1h,2h,2ah,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclobuta[i]chrysen-13-yl acetate
12-hydroxy-5a,5b,8,11a-tetramethyl-9-oxo-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
9,18-dihydroxy-2,16-dimethyl-15-{1-[2-(3-methylbutan-2-yl)cyclopropyl]ethyl}-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-4-en-3-one
2,3-dihydroxy-24-nor-4(23),12-oleanadien-28-oic acid; (2α,3β)-form
{"Ingredient_id": "HBIN004041","Ingredient_name": "2,3-dihydroxy-24-nor-4(23),12-oleanadien-28-oic acid; (2\u03b1,3\u03b2)-form","Alias": "NA","Ingredient_formula": "C29H44O4","Ingredient_Smile": "NA","Ingredient_weight": "456.66","OB_score": "NA","CAS_id": "189116-23-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8939","PubChem_id": "NA","DrugBank_id": "NA"}
2α,3α-dihydroxy-30-noroleana-12,20(29)-dien-28-oicacid
{"Ingredient_id": "HBIN005183","Ingredient_name": "2\u03b1,3\u03b1-dihydroxy-30-noroleana-12,20(29)-dien-28-oicacid","Alias": "NA","Ingredient_formula": "C29H44O4","Ingredient_Smile": "CC1(C2CCC3(C(C2(CC(C1O)O)C)CC=C4C3(CCC5(C4CC(=C)CC5)C(=O)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6049","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2α,3β-dihydroxy-30-noroleana-12,20(29)-dien-28-oicacid
{"Ingredient_id": "HBIN005225","Ingredient_name": "2\u03b1,3\u03b2-dihydroxy-30-noroleana-12,20(29)-dien-28-oicacid","Alias": "NA","Ingredient_formula": "C29H44O4","Ingredient_Smile": "CC1(C2CCC3(C(C2(CC(C1O)O)C)CC=C4C3(CCC5(C4CC(=C)CC5)C(=O)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6050","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}